 reduct granulocyt colony-stimul factor fever neutropenia chemotherapi patient small-cel lung cancer background neutropenia infect major dose-limit side effect chemotherapi previou studi recombin methionyl granulocyt colony-stimul factor g-csf chemotherapy-rel neutropenia patient cancer random clinic trial hypothesi clinic implic method patient small-cel lung cancer multicent double-blind placebo-control trial recombin g-csf incid infect fever neutropenia absolut neutrophil count liter temperatur equal degre cycl chemotherapi cyclophosphamid doxorubicin patient placebo g-csf treatment day day cycl result safeti studi treatment patient drug efficaci episod fever neutropenia percent placebo group percent g-csf group cycl chemotherapi median durat grade IV neutropenia absolut neutrophil count liter day placebo day g-csf cycl blind treatment number day treatment intraven antibiot number day hospit incid confirm infect percent g-csf placebo mild-to-moder medullari bone pain percent patient g-csf conclus use g-csf adjunct patient small-cel cancer lung reduct incid fever neutropenia culture-confirm infect incid durat sever grade IV neutropenia total number day treatment intraven antibiot day hospit